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The proliferation of normal human T lymphocytes involves an initial activation by 
antigen or lectin followed by a growth stimulus provided by a lymphokine-designated 
T  cell growth factor (TCGF). 1 TCGF is present in the conditioned media (CM)  of 
mitogen-stimulated human mononuclear cells and is probably released by a subset of 
T  lymphocytes. The addition of TCGF to activated T  cells allows their growth in 
liquid suspension culture for long periods (1, 2). This culture system is now widely 
used, and has been extended to several animals as well as to man (for recent reviews 
see 3, 4). 
Recent studies from our laboratory (5)  and others'  (6-8)  have clearly shown that 
TCGF purified free of antigen or lectin, and not the antigen or lectin, supports the 
growth  of T  cells.  The  role  of the  antigen  in  this  process  appears  to  be  both  to 
stimulate the TCGF-producer  cell  to  produce  TCGF and  to  activate  the TCGF- 
responder cell so that it becomes capable of binding TCGF (5-8).  Purification and 
characterization  of human TCGF  obtained  from  the  CM  of phytohemagglutinin 
(PHA)-stimulated peripheral  blood mononuclear cells pooled from several healthy 
donors (5) has shown that this molecule is a small protein (-13,000 mol wt) that can 
aggregate to larger molecular weight forms,  2 and is the sole requirement for long-term 
growth of activated T  cells.  Other recent results suggest that at least some forms of 
the protein are glycosylated (9). 
In contrast to normal T cells, which demonstrate an absolute requirement for prior 
lectin or antigen stimulation for response to TCGF, neoplastic cells of mature T  cell 
origin  (sheep  erythrocyte  receptor  positive,  terminal  deoxynucleotidyl transferase 
[TdT] negative) respond directly to lectin-free partially purified TCGF (10). Through 
exploitation of this property, TCGF-dependent cell lines expressing phenotypic char- 
* To whom reprint requests  should be addressed  at the National Cancer Institute, Building 37, Room 
6B04, Bethesda,  Md. 20205. 
1 Abbreviations used in this paper: BSS, basic salt solution; CM, conditioned media; CSA, colony-stimulating 
activity; CTCL, cutaneous T  cell lymphoma-leukemia cells; FCS, fetal calf serum;  IM, infectious  mono- 
neucleosis; PBL, peripheral blood leukocytes;  PBS, phosphate-buffered saline; PHA, phytohemagglutinin; 
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ppTCGF, partially purified TCGF. 
2 Mier, J.  W.,  and  R.  C.  Gallo.  Purification  and  some properties  of human  T  cell  growth  factor. 
Submitted for publication. 
Journal of Experimental Medicine • Volume 154, November 1981  1403 1404  T  LYMPHOMAS  PRODUCE  AND  RESPOND  TO  T  CELL  GROWTH  FACTOR 
acteristics consistent with  the  tumor cells of origin have  been  derived  from  several 
samples of cutaneous T  cell lymphomas and  leukemias (CTCL)  (10,  11)  and T  cell 
acute lymphoid leukemias (10). Two of these CTCL  cell lines, HUT-102 and CTCL- 
2, initially dependent on TCGF for growth, have lost their requirement for exogenous 
TCGF  after serial passage.  The reason  for this transformation  is unknown,  but  the 
autonomous growth of these cells may be due to constitutive production of TCGF or 
a  related molecule eliminating the need for exogenous TCGF. 
In  this  paper  we  report  the  following observations:  (a)  TCGF  is  constitutively 
produced  by  three human  neoplastic CTCL  lines and  this  activity is  found  in  the 
conditioned media and on the cell surface of these lines; (b) TCGF activity is adsorbed 
by these lines and not by other human tumor cell lines; and (c) the rate of proliferation 
of these cell lines can be increased by the addition of TCGF. These data suggest that 
TCGF or a  related molecule is an essential component of the continuous proliferation 
of these  transformed  T  cell  lines.  It  is possible that  a  major  abnormality  in  these 
disorders is the capacity of the same malignant cell to produce and respond to its own 
growth  factor.  Since established cell lines of neoplastic mature T  cells that  produce 
their own TCGF  and grow independent of exogenous TCGF  are unusual  (3 lines of 
>30 attempts), an alternative interpretation, and one more consistent with the results, 
is that production and response to TCGF  by the same cell ("autostimulation")  is an 
unusual  variant  of some  transformed  mature  T  cells  that  is  not  essential  to  their 
neoplastic conversion but favors their selective growth as established cell lines. 
Materials  and  Methods 
Preparation of TCGF  from Normal Human Peripheral Blood Leukocytes.  Heparinized whole human 
blood from normal donors mixed with plasmagel (0.3  ml/ml blood) was incubated without 
agitation at 37°C for 1 h. The leukocyte-rich plasma was collected and passed through nylon 
fiber filled columns (Dupont type 200 nylon, DuPont Instruments, Wilmington, Del.), The cell 
pellet resuspended in culture media was mixed with  10-20 similarly prepared cell pellets from 
ABO-compatible donors. CM containing TCGF was prepared by incubating l0  s leukocytes/ml 
in  tissue  culture  media  containing  0.25%  bovine  serum  albumin  and  1%  PHA-M  (Difco 
Laboratories, Detroit, Mich.) at 37°C for 72 h  (12,  13). The cell-free CM was then collected, 
filtered under sterile conditions, and stored at -20°C. Partially purifed TCGF was prepared by 
precipitation with  (NH4)2SO4  and  fractionation on a  DEAE°Sephrose column  as previously 
described (5). This material was sterilized and stored at 4°C before use. 
Cultured TCells. Long-term cultures of human T cells were maintained as previously described 
(1,  2). These cultures were resuspended at  5  X  105 cells/ml in crude CM containing TCGF 
(50% vol:vol). After 4-5 d, the cells reached a saturation density of 1-2 ×  106 cells/ml and were 
diluted to 5 X  105 cells/ml by the addition of fresh TCGF-containing media. This process was 
repeated every 4-5 d. 
TCGF Assay.  To estimate the amount of TCGF present in any sample, a  microassay was 
used as previously described (13, 14). Normal T cells initially activated with PHA were cultured 
for 20 d in the presence of added TCGF. These cells can not proliferate without TCGF and can 
be used as target cells in the TCGF assay. Such cells, kept at their saturation density for 24 h, 
were washed free of TCGF, resuspended in media containing 15% fetal calf serum (FCS), and 
placed in 96-well microplates (no. 3596, Costar, Data Packaging, Cambridge, Mass.) at 2 ×  104 
cells/well. An equal volume of a serial dilution of the sample to be assayed was then added. 
After incubation for 48 h, 0.5 ~Ci of [aH]TdR (specific activity 0.36 Ci/rnM, Schwartz/Mann 
Div., Becton, Dickinson & Co., Orangeburg, N. Y.) were added to each well. After incubation 
for an additional 16 h, cultures were harvested on glass fiber filter strips for determination of 
[aH]TdR  incorporation.  The  amount  of TCGF  is  estimated  from  an  analysis of the  dose- 
response  kinetics of serial  dilutions of the  test  sample  (13,  14). Briefly, a  standard  TCGF 
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counts per minute (cpm). Further dilution points are expressed as a percentage of the maximum 
cpm  and  the TCGF activity of each  test sample is then  determined  from  a  regression line 
generated by serial dilutions of the sample. 
Cell Lines.  All TCGF-independent cell lines including HUT-102,  HUT-78, and CTCL-2, 
cell lines derived from  CTCL  samples  (11,  12),  were  grown  in  RPMI  1640  (Grand  Island 
Biological Company, Grand Island, N.  Y.)  containing  10%  heat-inactivated FCS  (Biofluids, 
Rockville, Md.). HUT-102 and CTCL-2 initially required TCGF for growth; HUT-78 initially 
required concanavalin A for growth. However, after serial passage, growth of these cells became 
independent of these factors. The lymphoblastoid cell lines, Daudi, HSB-2, CCRF-CEM, EB- 
3,  and  RPMI  8866  were received from The  American Type Culture  Collection (Rockville, 
Md.). All other lymphoblastoid were a gift from Dr. J. Minowada (Buffalo, N. Y.). The TCGF- 
dependent CTCL cell lines were grown using partially purified TCGF as previously described 
(10), otherwise the conditions were the same as for the TCGF-independent cell lines. 
TCGF Production from  Human  Tumor Cell  Lines.  Various concentrations of PHA-P  (Difco 
Laboratories, Detroit, Mich.) with and without addition of phorbol myristate acetate (PMA) 
(10 ng/ml) were added to these cell lines cultured at cell concentrations of 106 and 107 cells/ml. 
CM  were  harvested  at  24-,  48-,  and  72-h  intervals,  concentrated  by  precipitation  with 
(NH4)2SO4  (5), and assayed for TCGF activity as described above. 
Acid Glycine Elution of TCGF.  Elution of cell surface proteins of cells was accomplished using 
published procedures (15). In brief, cells were washed in Dulbecco's phosphate-buffered saline 
(PBS), centrifuged at  1,800 rpm for 15 min, and the resultant cell pellet resuspended in 0.2 M 
glycine, pH 2.8,  at a cell density of 2 ×  l0  s cells/ml. After incubation at 4°C for 15 min, the 
cells were removed by centrifugation, and the supernate titrated to pH 7 by addition of solid 
Tris base. The supernate was then concentrated 10-20-fold by precipitation with (NH4)2SO4 as 
previously described (5). 
Response of CTCL Lines to Exogenous TCGF.  Cells were incubated in media containing the 
desired concentration of TCGF or media alone at  37°C.  Media was replenished daily.  1-ml 
aliquots  were  incubated  daily  with  0.5  /~Ci/ml  of  [3H]TdR  for  18  h  and  the  [3H]TdR 
incorporation was used to determine a stimulation index of: 
epm [3H]TdR incorporation with TCGF 
cpm [3H]TdR incorporation without TCGF 
Cell counts were done by the trypan blue exclusion method and sheep erythrocyte (E)  rosette 
determination was done by standard methods (16). 
Adsorption of TCGF.  All procedures were performed at 4°C. Cells were washed twice with 
PBS and incubated for varying lengths of time as defined in Results at several cell concentrations 
with partially purifed TCGF diluted to yield 50% of its maximum thymidine incorporation. 
This diluted sample was tested to ensure that  experimental loss of TCGF would fall on the 
linear portion of the sigmoid dose-response curve (14). After the incubation period, the cellular 
material was removed by centrifugation and serial dilutions of the resulting supernates were 
tested for TCGF activity in a  microassay. Regression lines were drawn  from the data points 
and the fraction of TCGF activity remaining after incubation was calculated as shown in Fig. 
1. In this example, a  regression line was calculated from data points generated by serial log2 
dilutions of an unadsorbed sample of partially purified TCGF  (ppTCGF) and a  second line 
derived from data of the identical ppTCGF preparation adsorbed with 2 ×  107 CTCL-2 cells 
for 2 h. The slope of the line of adsorbed material divided by the slope of the line of unadsorbed 
material equals the TCGF remaining (30% in this case). 
Adsorptions using  cell  membranes  prepared  as  described below  were  performed  under 
identical conditions. The  membranes were removed by centrifugation at  25,000  rpm for 20 
rain. Other adsorptions were performed in the presence of 0.1  mM phenylmethosulfofluoride 
(PMSF), 0.1% sodium azide, or a mixture of protease inhibitors (PMSF,  1% trasylol, 1 mM  l- 
tosylamido-2-phenylethylchloromethyl ketone  [TPCK]  and  1  mM  Na-p-tosyl-lysinechloro- 
methyl ketone [TLCK]). In these cases the cells were pretreated with the inhibitor at 37°C for 
30  min  the  adsorptions were  performed at  4°C  in  the presence of the inhibitor(s), and  the 
absorbed CM were dialyzed against PBS for 72 h before assaying for TCGF. Using previously 
published methods (17) to assay for granulocyte-macrophage colony-stimulating activity (CSA), 1406  T  LYMPHOMAS  PRODUCE  AND  RESPOND  TO  T  CELL  GROWTH  FACTOR 
10.0- 
x 
E 
•  5.0- 
o. 
m 
"o 
I-- 
"1" 
¢o 
0 
Sample Dilution 
Fro.  1.  Analysis of TCGF adsorption experiments. A standard ~reparation of partially purified 
TCGF was diluted to a concentration of TCGF which stimulated [ H]TdR incorporation in a linear 
manner when serially diluted. TCGF was measured in a microassay as described in Materials and 
Methods.  Linear  regression  curves  were  drawn  for  serial  dilutions  for  both  control  (O)  and 
experimental (0) data. The TCGF activity remaining in the "adsorbed" media was determined as 
described in Materials and Methods. CTCL-2 at 2 ×  107 cells/ml was incubated with TCGF for 2 
h at 4°C, 
adsorptions with CSA were carried out  to serve as a  control for the specificity of the TCGF 
adsorption• The source of CSA was human placental conditioned media made under serum- 
free conditions,  a 
Preparation of Plasma Membranes.  The method used was adapted from one described for cell 
fractionation of Raji cells (18). Cells previously  a incubated for 30 min in  1 mM chloroquine (to 
prevent lysosomal fusion) suspended at 5 ×  I0/ml  in Earle s basic salt solution (BSS), pH 8.0, 
were slowly mixed with sufficient 90% glycerol in BSS at 37°C over a  20-rain interval to yield 
a  40%  solution•  All  subsequent  steps  were  performed  at  4°C.  The  cells  were  then  pelleted, 
resuspended  in  Tris-HCl  buffer,  pH  7.4,  containing  1  mM  CaCI2  and  1  mM  MgCI~,  and 
disrupted using a  Dounce apparatus. The material was centrifuged at  1,000 g  for  I0 rain and 
the pellet was disrupted and centrifuged again. The combined supernates (S100) were layered 
over a  38% sucrose cushion and centrifuged at 25,000 rpm for 2 h  using a  SW27 rotor in a  L5- 
50 Ultracentrifuge (Beckman Instruments, Inc., Palo Alto, Calif.). The material at the interface 
was harvested, diluted to <12% sucrose with Tris-HCl buffer, pH 7.4, and centrifuged at 25,000 
rpm for20 rain. These fractions were assayed for thymidine 5'-phosphodiesterase (19), a plasma 
3 Ruscetti, F. W., J. Y. Chou, and R. C. Gallo.  1981. Human trophoblasts: cellular source of CSA in 
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membrane marker, fl-glueuronidase (20), a lysosomal marker, suecinate dehydrogenase (21), a 
mitochondrial marker, and glucose-6 phosphatase (22), a microsomal marker. 
Results 
Adsorption of TCGF by Activated Normal T  Lymphocytes.  Incubation  of a  standard 
preparation of TCGF with peripheral blood leukocytes (PBL)  previously stimulated 
with PHA for 5' or 7 d removed TCGF activity, and this result was directly related to 
the  cell  concentration  (Fig.  2).  Removal of TCGF was  also  time dependent;  some 
adsorption  occurred  within  10  rain  and  complete  adsorption  occurred  after  2  h. 
Incubation  at  4°C  for 2  h  with  6  ×  10  v PBL  stimulated  for  7  d  removed  all  the 
activity. Cells grown with ppTCGF retain their ability to adsorb TCGF after growth 
in culture for 20 or 90 d  (Fig.  2).  Four 6  ×  10  v cultured T  cells per ml incubated at 
4°C  for 2  h  removed all  the TCGF activity. Alloantigen-activated cultured  T  cells 
absorbed as well as lectin-activated T  cells (Table I). Removal of TCGF activity by 
cultured T  cells was not affected by the addition of 0.1  mM PMSF or 0.1% sodium 
azide in the incubation  mixture (Table I). Incubation of the adsorption  mixture at 
37°C reduced the time necessary to achieve a specified reduction in activity (data not 
shown). 
Lack of Adsorption of TCGF by Nonactivated Normal T Lymphocytes.  In contrast  to the 
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FXG.  2.  Comparison  of  adsorption  of TCGF  by  various  normal  human  T  cells.  Incubations 
containing different cell  populations at different concentrations were carried out with a  standard 
preparation of TCGF at 4°C for 4 h. Cells  used were the following: unstimulated normal human 
PBL (m); the same PBL stimulated by PHA for 7 d  (&); and cultured normal human T cells grown 
in the presence of TCGF for 14 d  (0). The cells were first  washed to remove residual TCGF before 
being  used  in  TCGF  adsorption  assays.  The  TCGF  activity  remaining  after  incubation  was 
determined as described in Fig.  1. 1408  T  LYMPHOMAS PRODUCE  AND  RESPOND TO T  CELL GROWTH FACTOR 
TABLE  I 
Effect of Various Conditions on the Ability  of Normal T Cells to Adsorb 
TCGF Activity 
Number of cells  Additions to ad-  TCGF  Activation of T cells*  (used to ad- 
sorption media~:  sorb)  removed§ 
% 
PHA + TCGF  None  5 X 107  91 
PHA + TCGF  PMSF  5 X 10  7  97 
PHA + TCGF  NA azidel[  5 x  10  7  99 
Alloantigen  None  5 X 10 7  86 
In vivo by IM¶  None  5 ×  107  93 
NA  PMSF  10  s  11 
NA  None  l0  s  5 
* Mononuclear cells  isolated from peripheral blood were stimulated with PHA- 
P (1 #g/ml)  or  10  s mitomycin C-treated cells/ml from histoincompatible 
donors for 5 d and grown in partially purified TCGF (10% vol:vol).  All cells 
were in culture for at least 3 wk before use. T cells isolated from a patient 
with infectious  mononucleosis  and unstimulated ceils were adsorbed without 
prior culture. 
~: The adsorptions using PMSF and sodium azide were carried out as described 
in Materials and Methods. 
§ All adsorptions were performed at 4°C for 2 h. The standard preparation of 
TCGF stimulated [3H]TdR incorporation of 18-25,000 cpm at maximum. 
The TCGF rem'ved was determined as described in Materials and Methods. 
11 NA indicates cells not activated. 
¶ Cells used in this experiment were mononuclear cells from a patient in an 
active phase of the disease. 
results in the last section, incubation of a  standard preparation of TCGF at 4°C for 
4 h with 10  s freshly isolated unstimulated PBL per ml removed only 4% of the TCGF 
activity (Fig. 2). At cell concentrations to 2 ×  10S/ml and 5 ×  10S/ml, the amount of 
TCGF activity removed increased to 9  and  18%,  respectively. In these experiments, 
adsorption  of TCGF  was  always  carried  out  using T  ceils  activated  in  vitro  by 
conventional methods. It was of interest to know whether similar adsorption would 
occur with T  cells activated in vivo by natural defense mechanisms. Therefore the 
ability of freshly isolated T  ceils from a patient with infectious mononucleosis (IM) to 
adsorb TCGF was also studied. These T  cells were able to adsorb TCGF in a manner 
similar to that of cultured T  cells without requiring in vitro activation (Table I). 
Adsorption  of  TCGF  by  CTCL  but  Not  by  Other  Human  Leukemic  Cell  Types.  The 
standard preparation of TCGF was incubated with the following human lymphoblast 
cell lines: SC-1, B cell in origin, NALM-1, pre-T pre-B cell, CCRF-CEM, immature 
T  cell,  HUT-102, CTCL-2,  and  HUT-78, three  lines of mature  neoplastic T  cells 
referred to as CTCL. The number of cells used ranged from 5  ×  106 to  108 cells/ml. 
HUT-102 removed TCGF activity in a cell concentration- (Fig. 3) and time-dependent 
manner. Adsorption occurred with as  few as 5  ×  106 cells. This adsorption was not 
affected  by  the  presence  of  PMSF  or  sodium  azide  in  the  incubation  mixture. 
Incubation with 2 ×  107 HUT-102 cells at 4°C for 2 h  removed all activity. None of 
the other cell lines removed >7% of the activity even when  l0  s cells were incubated 
for 4  h  (Fig.  3).  Several other human lymphoblast cell lines were  assayed  for  their 
ability to adsorb TCGF by incubating 108 cells for 4 h  at 4°C with TCGF (Table II). GOOTENBERG, RUSCETTI, MIER, GAZDAR, AND GALLO  1409 
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FIG. 3.  Comparison  of adsorption of TCGF by human neoplastic lymphoid  cell lines. Incubation 
with different cell lines (grown with RPMI 1640 with 10% FCS) at different concentrations was 
carried out with a standard preparation of TCGF at 4°C for 4 h. Cells used were HUT-102 (Q), 
SC-1 ('),  and  CCRF-CEM (A). The TCGF remaining after incubation was determined as 
described in Fig. I. 
Only  the  two  other  CTCL cell  lines,  HUT-78  and  CTCL-2,  removed  significant 
amounts of TCGF.  When  HUT-102 was  incubated  with  a  mixture  of TCGF and 
granulocyte-macrophage CSA, the TCGF activity was completely removed, but there 
was no significant removal of the CSA. 
Cell membranes prepared from HUT-102 cells  previously incubated with chloro- 
quine were similarly active in removing TCGF activity but not CSA activity (Table 
III). Adsorptions using cell  membrane preparations  performed in  the presence of a 
mixture of protease inhibitors  (PMSF, TLCK, TPCK, and trasylol)  also resulted in 
complete removal of TCGF activity (Table III). 
Constitutive  TCGF  Production  by  Some Human  T  Cell  Lymphoma-Leukemia  Cell 
Lines.  Conditioned  media  from  a  variety  of human  tumor  cell  lines  grown  to 
saturation density were collected, concentrated by precipitation with (NH4)2SO4, and 
tested for TCGF activity (Table IV). Of the cell lines tested in this manner, only CM 
from the  three CTCL lines  stimulated  [aH]TdR incorporation  in  a  microassay for 
TCGF (Table IV). Attempts to induce the cell lines not constitutively releasing TCGF 
to  produce TCGF,  or  to  induce  the  three  CTCL lines  to  make  appreciably more 
TCGF by exposure to PHA and/or PMA, were unsuccessful. Medium supplemented 
with  a  20-fold  (NH4)zSO4  concentrate  of HUT-102  CM  was  able  to  support  the 
growth ofT cells in long-term culture (Fig. 4). The TCGF released by the lymphoma- 
leukemia T  cells  is termed L-TCGF to distinguish it  from TCGF released by normal 
T  cells now referred to as N-TCGF. 1410  T  LYMPHOMAS  PRODUCE  AND  RESPOND  TO  T  CELL  GROWTH  FACTOR 
TABLE  II 
Comparison of TCGF Adsorption by Various Human Cell Lines 
Number of cells  TCGF re- 
Cell  lines  Origin*  Cell  type:~  (used to adsorb)  moved§ 
CCRF-CEM  ALL  Immature T  l0  s  3 
HSB-2  ALL  Immature T  10  s  7 
Daudi  BL  Neoplastic B  10  s  5 
SC-1  --  Normal B  l0  s  0 
U937  H L  Monocyte  10  s  7 
Nalm- 1  ALL  Pre-T pre-B  l0  s  0 
CTCL-2  SS  Mature T  2 X  107  63 
CTCL-2  SS  Mature T  5 X  l0  T  98 
HUT-78  MF  Mature T  5 x  l0  T  91 
* The  designations are  acute  lymphoblastic  leukemia  (ALL),  Burkitt's  lymphoma 
(BL),  histiocytic  lymphoma (HL),  S~zary  syndrome (SS),  and  mycosis fungoides 
(MF). 
Mature T  cells were E-rosette positive and TdT negative, whereas immature T  cells 
were  TdT  positive.  B  cells  were  surface  immunoglobulin positive.  Nalm-1  had 
intracellular p-chains and was TdT positive. 
§ All  adsorptions were carried out at 4°C for 2 h with the samples unable to adsorb 
being incubated  for 2 additional  h. The standard TCGF preparation stimulated 
[aH]TdR  incorporation of 18-25,000  cpm at maximum. The TCGF removed was 
determined as described in Materials and Methods. 
TABLE  III 
Adsorptions Using Coincubation of TCGF and CSA 
HUT-102 material 
CSA activity*  TCGF activity:l: 
Colonies/  Percent re-  Units/ml  Percent re- 
2 ×  10  ~ cells  maining  maining 
None  67  100  5.3  100 
Cells§  63  94  0.2  3 
Plasma membrane 111  64  96  0.5  10 
Plasma membrane 211  55  82  0.8  16 
* CSA activity was assessed using 2 ×  105 nonadherent bone marrow cells  per plate 
in methylcellulose (17). After 14 d of incubation, colonies of>50 cells were counted. 
The source of CSA was conditioned  media  prepared  from human placenta  cells 
under serum-free conditions  3 mixed with partially purified TCGF in a ratio of ~60 
colonies/2 ×  10  ~ marrow cells to 5 U of TCGF (the standard preparation used in all 
the other adsorption experiments was given a value of 10 U/ml). 
TCGF activity  was assayed as described  in  Materials  and  Methods.  Incubations 
were performed at 4°C for 2 h in the presence of 0.1 mM PMSF,  1% trasylol, 1 mM 
TLCK, and  1 mM TPCK.  Samples were extensively dialyzed  against  1,000 times 
volume of PBS  for 3  d  before assay. The  mixture of CSA  and  TCGF  used  was 
described above. 
§ HUT-102 cells at a concentration of 2.5 X  10  7 cells/ml were used in an incubation 
with a mixture of CSA and TCGF as described above. 
IlCell membranes were prepared from HUT-102 cells preincubated with chloroquine 
as described in Materials and Methods. This membrane fraction contained 70% of 
the total 5'-thymidine-phosphodiesterase activity,  a  plasma membrane marker (20) 
(See Table VI). Plasma membrane fractions  1 and 2, containing 2 and 0.4  mg/ml 
protein, respectively, were incubated with a mixture of TCGF and CSA as described 
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TABLE  IV 
Screening of Human Lymphoma-Leukemia Cells  for Constitutive Production of TCGF 
Cutaneous T  cell lym-  TCGF activity~ 
phoma* 
[aH]TdR cpm 
HUT-102  13,000 ±  3,800 
HUT-78  5,600 ±  1,700 
CTCL-2  3,600 ±  980 
Standard TCGF  18,000 ±  780 
Cell lines with no activity§ 
T  cell Leukemia  B cell lym-  Non-T, non-B 
phoma-leukemia  neoplasias 
CCRF-CEM 
CCRF-HSB2 
Molt-4 
8402 
T-45 
PEER- 
HPB-ALL 
HPB-MLT 
JM 
SKW3 
TALL- 1 
RAMOS  NALM- 1 
RAJI  NALM-16 
DAUDI  ML-I-3 
RPMI  1788  U937 
RPMI 8866  KG- 1 
LPN2  K562 
B  JAB  HL-60 
EB-3  DHL-2 
KM-3 
REH 
NALL- 1 
* All cell lines were grown in RPMI 1640 with 10% FCS. The conditioned media were concentrated 10-20- 
fold by ammonium sulfate precipitation before assaying for TCGF. 
:~ TCGF activity w~  measured using the microassay for [aH]TdR incorporation as described in Materials 
and Methods. All media were first concentrated by ammonium sulfate precipitation.  Experiments were 
done in triplicate +  SE. 
§ These cell lines were all treated in an identical manner to CTCL cell lines. No detectable TCGF activity 
was found with and without stimulation with PHA at various concentrations. 
r 
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FIo.  4.  Growth of cultured T  cells using eluated or conditioned media from HUT-102. Cultured 
normal human T  cells were first grown in N-TCGF for 22 d  after an initial stimulation with PHA. 
The cells were washed with warm RPMI  1640 to remove residual TCGF and then used as target 
cells for TCGF assays as follows. They were cultured in RPMI  1640 containing 10% FCS and the 
following materials:  HUT-102 acid eluate 50%  (vol/vol)  (m); a  second HUT-102 acid eluate 50% 
(vol/vol)  (0);  HUT-102  conditioned  media  (A);  and  control  (no  additive)  (×).  All  HUT-102 
material was concentrated  10-fold by ammonium sulfate precipitation before use. Cell counts were 
performed every 3-4 d. 1412  T  LYMPHOMAS  PRODUCE  AND  RESPOND  TO T  CELL GROWTH  FACTOR 
Elution of TCGF  from  Cell Surfaces and lsolated Membranes of CTCL and PHA-stimulated 
Normal T Cells.  Eluates were prepared from  1-2 g of various cell lines using an acid 
glycine buffer (pH 2.8). Only eluates from two CTCL  lines (HUT-102  and HUT-78) 
and PHA-stimulated PBL stimulated incorporation of [3H]TdR in the microassay for 
TCGF  (Table  V).  CTCL-2  was  not  tested  due  to  a  difficulty  in  obtaining  large 
quantities of cells. HUT-102  eluates were also to support the growth of T  cells (Fig. 
4),  a  more  definitive  test  for  TCGF  than  the  [ZH]TdR  incorporation  microassay 
described above. Cells grown for over 3 wk in the eluate material were >90% E-rosette 
positive. The amount of TCGF eluted from the HUT-102 cells was cell concentration 
dependent and detectable at 2 ×  l0  s cell/ml (Table V). TCGF activity was also found 
in the cell eluate (concentrated  100 times) made under conditions which maintained 
cell viability of >70%  (107  cells/ml,  1 min  incubation  at  4°C  in  glycine buffer,  pH 
2.8). 
Cell  membranes  prepared  from  HUT-102  cells were  also eluted  and  the  eluates 
yielded detectable TCGF  activity (Table VI). The cell membrane fraction contained 
70% of the phosphodiesterase I activity and 77% of the TCGF  activity. The cytoplas- 
mic fractions and nuclear membrane eluate contained minimal TCGF. However, the 
mitochondrial cell  pellet, which  probably contained  some  plasma  membrane,  also 
contained  activity, but  much  less  than  the  plasma  membrane  fraction  having  no 
succinate dehydrogenase activity (data not shown). 
Growth of Activated but Not of Unstimulated T Cells by TCGF  from Normal Activated T Cells 
and from  CTCL  Lines.  A  comparison  of L-TCGF  and  N-TCGF  showed  that  they 
possess  similar  biologic  functions  (Fig.  5).  Freshly  isolated  PBL  incubated  in  the 
presence of either L-TCGF eluates, CM, or N-TCGF CM for 3-7 d showed no increase 
in  [3H]TdR  incorporation.  The  same  PBL  used  after  5  d  of  PHA  stimulation 
incorporated thymidine  75-100-fold above background  in the presence of either L- 
TCGF  or N-TCGF materials. 
Enhanced Proliferation of TCGF-dependent and TCGF-independent CTCL Lines in Response 
TABLE V 
TCGF Activity Detectable by Acid Glycine Elution 
Cell number/ 
Ceils*  eluate:t:  TCGF activity§ 
no./ml  [ *HI TdR cpm 
HUT-102  2 ×  l0  s  20,300 :t: 2,600 
HUT-78  2 ×  108  5,100 +  1,700 
PHA-stimulated PBL  l0  s  12,700 + 2,100 
HSB-2  5 ×  108  150 ±  110 
NALM-1  108  522 ±  152 
Molt-4  2 ×  l0  s  270 ±  190 
DAUDI  2 ×  10  s  650 :k 190 
Nonstimulated  PBL  109  180 ± 30 
Standard TCGF  --  9,800 :t: 1,400 
* All cell lines were grown on RPMI 1640 containing  10% FCS. 
An acid eluate was made using glycine buffer (pH 2.8) at 4°C for 10 min. 
After extensive dialysis, the elutates were assayed for TCGF. 
§ TCGF activity was measured using the microassay for [ZH]TdR incorpora- 
tion as described in Materials and Methods. All media were first concentrated 
by ammonium  sulfate precipitation.  Experiments were done in triplicate -t- 
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TABLE  VI 
Subcellular Localization of TCGF Activity in HUT-I 02 Cells 
Cellular fraction 
Phosphodiesterase  I*  TCGF activity:]: 
8pecific  Relative  Total  [aH]TdR  TCGF 
activity 
activity  (lysate -- 1.0)  recovered  uptake  recovered 
#M Nitrophenol/ 
ms/h  %  cpm  % 
Lysate  0.039  1.0  --  ND§  ND§ 
Cytoplasm  0.010  0.3  17.0  1,020  8.5 
Nuclei pellet  0.016  0.4  7.5  35  1.3 
Mitochondrial pellet  0.028  0.7  5.0  3,400  12.9 
Plasma membrane  0.207  5.4  70.5  18,700  77.3 
*  Thymldine-5'-phosphodiesterase was  measured  using thymidine-5'-monophosphate-p-nitrophenol ester 
as substrate,  Units expressed  as micromoles p-nitrophenol released  per hour at pH 9.0. Specifc activity 
was calculated as units per milligram protein in sample.  Relative specific activity was derived by dividing 
the speclfle activity of each sample by the specific activity of the lysate used as starting material for the 
fractionation. Total activity recovered  was calculated by multiplying the enzyme units per 10/d assay 
sample by the total volume of each sample and then the fraction of the total activity contained in each 
fraction was determined. 
:~TCGF  activity  of concentrates  prepared  by  acid  elution  and  (NH,)2SO4  precipitation  of nuclear, 
mltoehondrlal,  and  plasma  membrane  particulate  fractions  and  (NH,)2SO4  precipitation  of soluble 
cytoplasmic fractions  was tested  in a  [ H]TdR ineo'poration mmroassay  as described  in Materials and 
Methods,  Relative TCGF potencies were derived by comparing the slopes of the ~eSresslorl lines gerietated 
by serial log~ dilution o£ the samples TCGF recovered was calculated by multipl~,ing the amount present 
in the assay by the total volume of the sample and expressed ~  a percentage o~ the total, 
§ Cell lysate was used as starting material for Pcactionation and was not assa~,ed for TCGtP, 
to  Exogenous TCGF.  Both  factor-independent  and  factor-dependent  CTCL  were 
grown in the presence of added exogenous TCGF. The addition of TCGF to HUT- 
102  cells  increased  their  incorporation  of  [nH]TdR  (Fig.  6)  in  a  concentration- 
dependent manner. The rate of proliferation of CTCL-2, another TCGF-independent 
CTCL cell line, increased during incubation with either L-TCGF or N-TCGF (Table 
VII). TCGF-dependent CTCL and acute lymphocytic leukemia cells proliferated in 
response to TCGF- and L-TCGF-containing acid eluates from HUT-102 in an equally 
efficient manner  (Table VII). 
Discussion 
The  addition  of TCGF  to  T  cells  previously activated  by antigen  or lectin  has 
allowed  the  routine  long-term  growth  of mature  normal  human  T  cells  (I,  2). 
Lymphocyte activation by antigen or lectin involves two distinct steps: stimulation of 
TCGF release and development of TCGF-responsive T cells. The development of the 
TCGF-responsive state appears to be mediated by the appearance of TCGF-specific 
membrane  binding  sites.  Consistent  with  this model, no detectable TCGF activity 
remains in the conditioned media of cultured T  cells  72-96 h after the addition of 
TCGF  (8), ,ugge~tlng  that  the prol[f~el~ating T  cells  inactivate or bind and  remove 
TCGF from the media. It has been pre~ciously shown that T cells activated by lectin 
or antigen  l-emove TCGP activity in a  time-, temperature-,  and cell  concentration~ 
dependent  manner  whereas utt~timulated  T  cells  or ceils  stimulated  with  a  B cell 
mitogen do not (6~8). Under the conditions described here, freshly isolated mortonu, 
clear cells removed ~ome TCGF activity but 0nly at high cell concentrations (3 X l0  g 1414  T  LYMPHOMAS  PRODUCE AND RESPOND  TO T  CELL GROWTH  FACTOR 
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Fro.  5.  Comparison of biologic activities of N-TCGF  and  L-TCGF.  (Panel A)  Unstimulated 
normal human  PBL were incubated  in media supplemented with PHA-P (10 #l/ml);  N-TCGF 
(10% vol/vol), or L-TCGF (20% vol/vol) for 3 d before [aH]TdR incorporation was determined. 
(Panel B) PBL were stimulated with PHA for 5 d. After washing, the cells were incubated in media 
supplemented with PHA-P (10 #l/ml),  N-TCGF (10% vol/vol), or L-TCGF (20% vol/vol) for 3 d 
before [3H]TdR incorporation was determined. 
cells  removed  18%  of the  TCGF  activity).  This  may  be  due  to  the  presence  in 
peripheral  blood  of a  minor  population  of activated  T  cells.  In  contrast,  T  cells 
activated either in vitro by PHA Or alloantigen or in vivo in the case of patient with 
IM completely adsorbed TCGF activity using only 5 ×  107 cells/ml. 
In contrast to TCGF adsorption mediated by normal antigen or lectin-activated T 
cells and similar to the resslts with T  cells derived from a patient with IM, cells lines 
derived from patients with cutaneous T  cell lymphoma and leukemia adsorbed TCGF 
without any apparent in vitro activation signal. For instance, HUT-102 cells removed 
all TCGF activity at a  cell concentration of 2  ×  107 cells, whereas 5  ×  107 normally 
activated T  cells  per ml were required  to remove all  activity using identical  TCGF 
preparations.  It is not known whether this  is a  result  of differences in the affinity of 
TCGF  receptor  binding,  or  receptor  density  per  cell,  or  both.  Incubation  at  4°C 
which  markedly  inhibits  endocytosis and  many other  metabolic  functions,  and  the 
addition  of metabolic,  proteolytic,  and  lysosomal  function  inhibitors  did  not  affect 
the  removal  of TCGF  activity.  Removal  of activity  seems  specific  for cell  lines  of 
mature T  cell origin because normal B cells, neoplastic B cells, neoplastic immature 
T  ceils, neoplastic pre-B cells, myeloid, and monocytoid cells failed to remove TCGF 
activity. The evidence that the removal of TCGF was not due to a  nonspecific event 
such  as TCGF  degradation  was  not  limited  to the  cell  specificity.  When normal  T 
cells  and  the  CTL cell  lines  were  incubated  with  a  mixture  of TCGF  and  CSA,  a 
growth factor specific for myeloid cells, all of the TCGF activity and none of the CSA 
activity was removed.  In addition,  incubation  of HUT-102 plasma  membrane  frac- 
tions  with  TCGF  and  CSA  in  the  presence  of proteolytic  inhibitors  gave  results GOOTENBERG,  RUSCETTI,  MIER,  GAZDAR,  AND  GALLO  1415 
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FXG. 6.  Response of HUT- 102 to added TCGF. HUT- 102 were cultured at an initial concentration 
of 5 ×  104 in RPMI  1640 containing 10% FCS with or without N-TCGF at either 20%  (C)) or 60% 
(0) vol/vol. The media were replenished daily. [3H]TdR incorporation was determined on aliquots 
daily. A stimulation index was determined as described in Materials and Methods. The flat line 
(also shown as solid circles, 0) represents HUT-102 cells grown in the absence of added TCGF and 
represents normalized (100%) growth. 
TABLE  VII 
Proliferation of Malignant T Cells in Response to N- TCGF and L- TCGF 
TCGF de-  Cells*  pendence 
Growth saturation density:~ 
Media  N-TCGF  L-TCGF 
CTCL-14  Yes  Dead  1.2 ×  10  s  1.2 ×  10  6 
ALL-16  Yes  Dead  1.0 X  10  6  1.0 X  10  6 
CTCL-2  No  2 ×  10  5  5.0 x  l0  s  4.0 ×  10  5 
* CTCL-2 was derived from a  patient with S~zary syndrome. It was initiated 
with TCGF  but  was  grown  independent of TCGF  for 26  wk  before use. 
CTCL-14,  derived  from  a  patient  with  mycosis  fungoides,  and  ALL-66, 
derived from a patient with T  cell acute lymphoid leukemias, were initiated 
and maintained in culture using partially purified TCGF for 5 and  10 wk, 
respectively, before use. 
:[:All  cell  lines  were  put  in  culture  at  10  s  cells/ml  in  RPMI  1640  media 
containing 10% FCS. Either TCGF was added at 50% (vol/vol). Cell counts 
were performed daily until the saturation density of the culture was reached 
in 5-7 d. L-TCGF was derived from acid elution of HUT-102 cells, and N- 
TCGF was derived from conditioned media from PHA-stimulated normal 
lymphocytes. 
identical  to those obtained  with  whole  cells. These  results strongly  suggest that  there 
are  specific TCGF  binding  sites on  the  cell  surface  of both  normal  activated  T  cells 
and  human  neoplastic  T  cell lines of mature  T  cell origin. 
Finally,  the  presence  of specific binding  sites for TCGF  on  the  CTCL  lines is also 1416  T  LYMPHOMAS PRODUCE AND RESPOND TO T  CELL GROWTH  FACTOR 
suggested by the presence of TCGF activity in the acid eluates from both HUT-102 
and  HUT-78 cells.  This TCGF appears to be associated with  the cell surface since 
TCGF activity was also eluted  from partially purified  plasma membrane fractions 
and  from cells that  retained  their  viability after the elution  procedure.  The eluted 
activity supported the growth of cultured T  cells, whereas eluates from several other 
cell lines had no activity. These results strongly suggest that there are specific TCGF 
binding sites on the cell surface of both normal activated T cells and human neoplastic 
T  cell lines of mature T  cell origin. 
The TCGF found  on the cell surfaces of these CTCL lines  is also present  in  the 
conditioned media of HUT-102, HUT-78, and CTCL-2. These three CTCL cell lines 
are the first human cell lines known to constitutively release TCGF. A  malignant T 
cell line developed from a  Gibbon ape spontaneously releases TCGF.  4 A  few murine 
tumor cell lines and one human cell line have been reported to produce TCGF but 
only upon induction with lectins and phorbol esters (23-25). A survey of other human 
tumor cell lines including several immature leukemic T  cell lines did not reveal any 
additional cell lines that could release TCGF either constitutively or upon induction. 
These results are consistent with both the helper T  cell nature of CTCL (26)  and the 
evidence that the normal TCGF producer cell is a helper T  cell (27, 28). 
The production of TCGF, the apparent presence of membrane receptors for TCGF, 
and the recovery of TCGF from the cell surface of these CTCL lines all suggest that 
these cell lines proliferate in response to endogenously produced TCGF. Addition of 
N-TCGF to HUT-102 cells augmented [3H]TdR incorporation  in a  dose-dependent 
manner.  Addition  of either L-TCGF or N-TCGF to CTCL-2  (another TCGF-inde- 
pendent  cell line)  and  to various TCGF-dependent  T  cell  lines of neoplastic origin 
resulted  in  increased proliferation of these cells. The results taken together indicate 
that these CTCL lines both produce and respond to L-TCGF. No normal T  cell line 
has  been  shown  both  to  constitutively  produce  and  respond  to  TCGF  (3,  4,  27). 
Cloned murine helper T  cells, which respond to TCGF, produced TCGF only when 
histocompatible macrophages and specific antigen are added  (27). 
The proliferation of CTCL may be due to the continuous production of TCGF by 
the same cell that expresses TCGF receptors on its cell surface. This is analogous to 
studies of growth regulations of anchorage-dependent tumor cell lines in which a few 
human tumor cell lines constitutively release protein factor(s)  that stimulate growth 
of normal and malignant human cell lines by binding to the normal epidermal growth 
factor  receptor  (29).  In  these  systems,  it  has  been  suggested  that  malignant  cells 
"autostimulate" their growth by producing and responding to these protein growth 
factor(s)  (30).  Single-cell cloning experiments using these cell lines are in progress to 
unambiguously  verify  whether  the  same  cell  produces  and  responds  to  TCGF. 
However, even if this is found it does not necessarily indicate that "self-stimulation" 
is an essential aspect of neoplasia. In fact, it is much more frequent to find neoplastic 
mature T  cells that maintain a requirement for exogenous TCGF for in vitro growth. 
Therefore, constitutive TCGF production and response by the same cell could simply 
be one of many unusual phenotypic variant properties of neoplastic cells which, when 
it occurs, gives them a selective advantage for in vitro growth. 
4 Rabin, H., R. F. Hopkins III, F. W. Ruscetti, R. H. Neubasuer, R. L. Brown, and T. G. Kawakami. 
A T cell tumor line derived from a Gibbon ape spontaneously releases T cell growth factor activity. 
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Summary 
Three cell lines of mature T  cell origin derived from patients with cutaneous T  cell 
lymphoma-leukemias  (CTCL)  were  found  to  be  constitutive  producers  of T  cell 
growth factor (L-TCGF). These are the first  reported human cell lines which consti- 
tutively  produce  TCGF.  Biologically active  TCGF  could  also  be  eluted  from  the 
surface of these cells  using an acid glycine buffer under conditions that  maintained 
cell viability, and subcellular fractionation showed that almost all the TCGF activity 
was associated with the plasma membrane. Over 30 other human hematopoietic cell 
lines derived from other disorders were unable to produce TCGF even after induction, 
and their acid eluates did not contain TCGF activity. L-TCGF from CTCL lines had 
the same biological activity as TCGF obtained from normal leukocytes (N-TCGF) in 
that they both supported the long-term growth of normal T  cells  only after the cells 
were previously activated by antigen or lectin. Both L-TCGF and N-TCGF increased 
the  rate  of proliferation  of TCGF-independent  and  TCGF-dependent  CTCL  cell 
lines.  The  same  three  factor-independent  cell  lines  that  released  TCGF  adsorbed 
TCGF in a cell-concentration, time-, and temperature-dependent manner. Since the 
CTCL cell lines produce TCGF, adsorb TCGF, and increase their proliferative rate 
in  response  to TCGF or a  related  molecule,  it  is  suggested that  this  endogenously 
produced factor plays a  role in maintaining the abnormal proliferation of these cells 
in  culture  as  permanently  growing  cell  lines  independent  of  exogenous  TCGF. 
However, this  does not  mean  that  this  is  an  essential  aspect of neoplastic  transfor- 
mation. Since it is unusual to develop these cell lines in the absence of the continuous 
need for added TCGF, "autostimulation" may be one of the many unusual variant 
phenotypic properties  sometimes associated with  neoplastic cells  that  gives them  a 
selective advantage for in vitro growth. 
We thank Anna Iacangelo, Joan Strawson,  and Andrea Woods for their excellent  technical 
assistance. 
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